Wang H, Jin C, Fang L, Sun H, Cheng W, HU S. Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review. Cost Effectiveness & Resource Allocation. 2020;18(1):1-8. https://t.co/aGhpf5OeOH
RT @radoncpapers: Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review. ht…
Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review. https://t.co/lh4v0aVQx9 h/t @NCBI #RadOnc #PubMed
Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review https://t.co/Kl3hsCVnfN
RT @LizHoffmanbmc: Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review ht…
Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review https://t.co/Br3lw3jCwe